Final answer:
Option C best represents the negative feedback mechanism involving hESC-β cells where increased insulin secretion by hESC-β cells leads to increased glucose uptake by body cells, followed by a decrease in insulin secretion.
Step-by-step explanation:
Based on the data, the best representation of how mice with implanted human embryonic stem cell-derived beta (hESC-β) cells use negative feedback to return blood glucose levels to normal if blood glucose levels increase is option C: Increased insulin secretion by hESC-β cells → increased glucose uptake by body cells → decreased insulin secretion by hESC-β cells.
This sequence accurately depicts the physiological process known as negative feedback, which involves the regulation of blood glucose levels. When blood glucose levels rise, hESC-β cells secrete insulin, which encourages body cells to uptake glucose, thereby reducing blood glucose levels. As a result, insulin secretion by the hESC-β cells decreases due to the lowered blood glucose, completing the negative feedback loop.